middle.news
Why Acrux’s Tube-Packaged Dapsone Gel Could Disrupt US Acne Treatments
2:55am on Monday 2nd of June, 2025 AEST
•
Pharmaceuticals
Read Story
Why Acrux’s Tube-Packaged Dapsone Gel Could Disrupt US Acne Treatments
2:55am on Monday 2nd of June, 2025 AEST
Key Points
Launch of Dapsone 7.5% Gel in US for acne treatment in children 9+
Product differentiated by eco-friendly tube packaging versus pump bottles
Manufactured and packaged in the United States
FDA approval granted for both tube and pump presentations
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Acrux (ASX:ACR)
OPEN ARTICLE